|
Browse on-demand webinars from SITC.
|
|
The SITC Advances in Cancer ImmunotherapyTM Webinar: Clinical Updates from ASCO 2021, held on October 6, 2021, is available for continuing education credits.
Continuing Education Credit Information
Continuing Education Credits are available for physicians, nurses and pharmacists. To view full accreditation information, click here.
Request Credit
- Click the Register Now button.
- You will be prompted to log in or create a free account.
- Click the Request Credit/Certificate button.
- On the Manage Your Credit screen, follow the instructions to select the Credit Reporting Organization you wish to claim credit for. (Note: For pharmacist completers, enter your NABP# (required). For physicians claiming MOC credit, enter your ABIM# (required)). Then click Continue.
- Successfully complete the post-test with a score of 75% or better.
- Complete the evaluation. Then click Submit.
- On the Confirm All Information screen, verify your Credit Reporting Organization and click Process Credit.
- On the Education Credit Profile screen, scroll down to the Submitted Credit section to view your certificate.
For Pharmacists: Upon completion of the online evaluation, your credit will be submitted to CPE Monitor. Parmacists have up to thirty (30) days to complete the evaluation and claim credit. Please check you NABP account within thirty (30) days to make sure the credit has posted.
Target Audience
The webinar is intended for clinical oncologists, registered nurses, nurse practitioners, advanced practice registered nurses, pharmacists, physician assistants, emergency physicians, allied health professionals, other patient care providers, students and patient advocates.
Webinar Learning Objectives
- Summarize the most recent advances in cancer immunotherapy
- Analyze cutting-edge clinical trials to incorporate new research and techniques into clinical application for cancer immunotherapy
- Describe the role of clinical and investigational biomarkers in cancer immunotherapy
Webinar Faculty
- Moderator: Evan J. Lipson, MD - Johns Hopkins Univeristy
- Presenters:
- Matthew Frigault, MD, MSc - Massachusetts General Hospital
- Ulka Vaishampayan, MD – University of Michigan
- Jarushka Naidoo, MBBCH, MHS – Beaumont RCSI Cancer Centre Dublin
On-demand Webinar
The recorded webinar video and slides will be available here within 24 hours after the webinar concludes.
(Please note that the on-demand webinars are not available for continuing education credits.)
Jointly provided by Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer.
The 2020–2021 Advances in Cancer Immunotherapy™ educational series is supported, in part, by independent medical education grants from Amgen, AstraZeneca Pharmaceuticals LP, Bristol Myers Squibb, Exelixis, Inc., and Merck & Co., Inc.
| | Original Course Date: October 06, 2021
| Approved Credit: ACCME (MD/DO): 1 hour AMA PRA Category 1 Credit(s)™ACCME (non-MD/DO): 1 hour AMA PRA Category 1 Credit(s)™ACPE: 1 hour Contact HourANCC: 1 hour Contact HourCoP: 0.00 hours Certificate of Participation: 1 hour AMA PRA Category 1 Credit(s)™ / ABIM Maintenance of Certification Part 2 Credit
| MORE INFO |
|
The SITC Advances in Cancer Immunotherapy™ Webinar: Clinical Updates from ESMO Immuno-Oncology Congress 2020, held on July 16, 2021, is available for continuing education credits.
Continuing Education Credit Information
Continuing Education Credits are available for physicians, nurses and pharmacists. To view full accreditation information, click here.
Request Credit
- Click the Register Now button.
- You will be prompted to log in or create a free account.
- Click the Request Credit/Certificate button.
- On the Manage Your Credit screen, follow the instructions to select the Credit Reporting Organization you wish to claim credit for. (Note: For pharmacist completers, enter your NABP# (required). For physicians claiming MOC credit, enter your ABIM# (required)). Then click Continue.
- Successfully complete the post-test with a score of 75% or better.
- Complete the evaluation. Then click Submit.
- On the Confirm All Information screen, verify your Credit Reporting Organization and click Process Credit.
- On the Education Credit Profile screen, scroll down to the Submitted Credit section to view your certificate.
For Pharmacists: Upon completion of the online evaluation, your credit will be submitted to CPE Monitor. Parmacists have up to thirty (30) days to complete the evaluation and claim credit. Please check you NABP account within thirty (30) days to make sure the credit has posted.
Target Audience
The webinar is intended for clinical oncologists, registered nurses, nurse practitioners, advanced practice registered nurses, pharmacists, physician assistants, emergency physicians, allied health professionals, other patient care providers, students and patient advocates.
Webinar Learning Objectives
- Summarize the most recent advances in cancer immunotherapy
- Analyze cutting-edge clinical trials to incorporate new research and techniques into clinical application for cancer immunotherapy
- Describe the role of clinical and investigational biomarkers in cancer immunotherapy
Webinar Faculty
- Moderator: Paolo A. Ascierto, MD – Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale'
- Presenters:
- Joseph Sacco, MBChB, MSc, MRCP, PhD – The Clatterbridge Cancer Centre
- Julia Katharina Schwarze, MD, MSc – University Hospital Brussels
- Sunandana Chandra, MD, MS – Northwestern University
On-demand Webinar
The recorded webinar video and slides will be available here within 24 hours after the webinar concludes.
(Please note that the on-demand webinars are not available for continuing education credits.)
Jointly provided by Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer.
The 2020–2021 Advances in Cancer Immunotherapy™ educational series is supported, in part, by independent medical education grants from Amgen, AstraZeneca Pharmaceuticals LP, Bristol Myers Squibb, Exelixis, Inc., and Merck & Co., Inc.
| | Original Course Date: July 08, 2021
On-Demand Release Date: Available Now | Approved Credit: ACCME (MD/DO): 1 hour AMA PRA Category 1 Credit(s)™ACCME (non-MD/DO): 1 hour AMA PRA Category 1 Credit(s)™ACPE: 1 hour Contact HourANCC: 1 hour Contact HourCoP: 0.00 hours Certificate of Participation: 1 hour AMA PRA Category 1 Credit(s)™ / ABIM Maintenance of Certification Part 2 Credit
| MORE INFO |
|
The SITC Advances in Cancer Immunotherapy™ Webinar: Clinical Updates from SITC 2020, held on March 30, 2021, is available for continuing education credits.
Continuing Education Credit Information
Continuing Education Credits are available for physicians, nurses and pharmacists. To view full accreditation information, click here.
Request Credit
- Click the Register Now button.
- You will be prompted to log in or create a free account.
- Click the Request Credit/Certificate button.
- On the Manage Your Credit screen, follow the instructions to select the Credit Reporting Organization you wish to claim credit for. (Note: For pharmacist completers, enter your NABP# (required). For physicians claiming MOC credit, enter your ABIM# (required)). Then click Continue.
- Successfully complete the post-test with a score of 75% or better.
- Complete the evaluation. Then click Submit.
- On the Confirm All Information screen, verify your Credit Reporting Organization and click Process Credit.
- On the Education Credit Profile screen, scroll down to the Submitted Credit section to view your certificate.
For Pharmacists: Upon completion of the online evaluation, your credit will be submitted to CPE Monitor. Parmacists have up to thirty (30) days to complete the evaluation and claim credit. Please check you NABP account within thirty (30) days to make sure the credit has posted.
Target Audience
The webinar is intended for clinical oncologists, registered nurses, nurse practitioners, advanced practice registered nurses, pharmacists, physician assistants, emergency physicians, allied health professionals, other patient care providers, students and patient advocates.
Webinar Learning Objectives
- Summarize and integrate the most recent advances in cancer immunotherapy
- Analyze cutting-edge clinical trials to incorporate new research and techniques into clinical application for cancer immunotherapy
- Define the types of resistance to PD-1 pathway inhibitors
Webinar Faculty
- Moderator: Jason Luke, MD – University of Pittsburgh Medical Center
- Presenters:
- Diwakar Davar, MD – University of Pittsburgh Medical Center
- Karl Lewis, MD – University of Colorado
- Ignacio Melero, MD, PhD – Fundación para la Investigación Médica Aplicada
- Hussein Tawbi, MD, PhD – MD Anderson Cancer Center
On-demand Webinar
The recorded webinar video and slides will be available here within 24 hours after the webinar concludes.
(Please note that the on-demand webinars are not available for continuing education credits.)
Jointly provided by Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer.
The 2020–2021 Advances in Cancer Immunotherapy™ educational series is supported, in part, by independent medical education grants from Amgen, AstraZeneca Pharmaceuticals LP, Bristol Myers Squibb, Exelixis, Inc., and Merck & Co., Inc.
| | Original Course Date: March 24, 2021
| Approved Credit: ACCME (MD/DO): 1 hour AMA PRA Category 1 Credit(s)™ACCME (non-MD/DO): 1 hour AMA PRA Category 1 Credit(s)™ACPE: 1 hour Contact HourANCC: 1 hour Contact HourCoP: 0.00 hours Certificate of Participation: 1 hour AMA PRA Category 1 Credit(s)™ / ABIM Maintenance of Certification Part 2 Credit
| MORE INFO |
| View Recorded Webinar
On June 9, 2020, leading experts in cancer immunotherapy discussed the latest advances in cancer immunotherapy emerging from ESMO Immuno-Oncology Congress 2019 during a live webinar.
Webinar Faculty
- Joshua Brody, MD – Icahn School of Medicine at Mount Sinai
- Ezra Cohen, MD – University of California San Diego
- Tanja de Gruijl, PhD (moderator) – VU University Medical Center
- Geoffrey Gibney, MD – Georgetown Lombardi Comprehensive Cancer Center
Webinar Date
June 9, 2020
Please note that the recorded webinar is not available for continuing education credits.
| | Original Course Date: June 08, 2020
| MORE INFO |
| View Recorded Webinar
On February 28, 2020, leading experts in cancer immunotherapy discussed the latest advances in cancer immunotherapy emerging from ESMO Congress 2019 during a live webinar.
Webinar Faculty
Leora Horn, MD – Vanderbilt University Medical Center
Amanda Kirane, MD – UC Davis Comprehensive Cancer Center
Brian Rini, MD – Vanderbilt University Medical Center
Webinar Date
February 28, 2020
Please note that the recorded webinar is not available for continuing education credits.
| | Original Course Date: February 28, 2020
| MORE INFO |
| View Recorded Webinar
On February 4, 2020, leading experts in cancer immunotherapy discussed the latest advances in cancer immunotherapy emerging from the Society for Immunotherapy of Cancer's 34th Annual Meeting & Pre-Conference Programs (SITC 2019) during a live webinar.
Webinar Faculty
Sanjiv Agarwala, MD – Temple University
Igor Puzanov, MD – Roswell Park Comprehensive Cancer Center
Anil Shanker, PhD – Meharry Medical College
Webinar Date
February 4, 2020
Please note that the recorded webinar is not available for continuing education credits.
| | Original Course Date: February 04, 2020
| MORE INFO |
| View Recorded Webinar
Webinar Description
On August 28, 2019, leading experts in cancer immunotherapy presented the latest advances in cancer immunotherapy emerging from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting.
The webinar summarized key studies on the following topics:
- Biomarkers and checkpoint inhibitors
- Cellular therapies
- First-line and neoadjuvant studies
Webinar attendees also had the opportunity to interact with the leading experts during a dedicated question-and-answer session.
Webinar Faculty
James L. Gulley, MD, PhD, FACP – National Cancer Institute
Kim A. Margolin, MD – City of Hope
Ahmand Tarhini, MD, PhD – Moffitt Comprehensive Cancer Center
Webinar Date
August 28, 2019
| | Original Course Date: August 28, 2019
| MORE INFO |
| View Recorded Webinar
Program Summary
This one-hour webinar, held on August 22, 2019, moderated by Tullia Bruno, PhD (University of Pittsburgh), and presented by Josh Henkin, PhD (STEM Career Services, LLC), Barbara J. Natalizio, PhD (The Rita Allen Foundation), and Yvette R. Seger, PhD (Federation of American Societies for Experimental Biology) taught early career scientists about obtaining and thriving in a career in science away from the bench.
These webinars are an extension of the Meet-the-Expert Lunch, a Pre-Conference Program of the SITC Annual Meeting, providing a unique educational forum for early career scientists. This popular program connects early career scientists with field experts who provide guidance on a variety of career-related topics.
Webinar Faculty
- Moderator: Tullia Bruno, PhD – Assistant Professor, University of Pittsburgh
- Presenters:
- Josh Henkin, PhD – Founder/Career Coach, STEM Career Services, LLC
- Barbara J. Natalizio, PhD – Communications and Scientific Engagement, The Rita Allen Foundation
- Yvette R. Seger, PhD – Deputy Director, Office of Public Affairs and Director of Science Policy, Federation of
Webinar Date
August 22, 2019
| | Original Course Date: August 22, 2019
| MORE INFO |
| View Recorded Webinar
Program Summary
With cutting-edge data regularly emerging from conferences and new FDA approvals, keeping updated with the latest cancer immunotherapy research is an arduous task for a practicing clinician. To complement and expand upon the live Advances in Cancer Immunotherapy™ (ACI) programs, SITC is proud to offer a series of quarterly webinars to highlight the latest advancements and trends in the field as they relate to clinical practice.
The focus of this webinar is on clinical updates presented at American Association for Cancer Research (AACR).
Webinar Faculty
Robert Canter, MD, MAS, FACS - University of California Davis Healthy System
Robert L. Ferris, MD, PhD - UPMC Hillman Cancer Center
Webinar Date
May 23, 2019
| | Original Course Date: May 23, 2019
| MORE INFO |
| View Recorded Webinar
Program Summary
With cutting-edge data regularly emerging from conferences and new FDA approvals, keeping updated with the latest cancer immunotherapy research is an arduous task for a practicing clinician. To complement and expand upon the live Advances in Cancer Immunotherapy™ (ACI) programs, SITC is proud to offer a series of quarterly webinars to highlight the latest advancements and trends in the field as they relate to clinical practice.
The focus of this webinar is on clinical updates presented at ESMO Immuno-Oncology Congress 2018.
Webinar Faculty
May Cho, MD - UC Davis Comprehensive Cancer Center
Terence Rhodes, MD, PhD - Intermountain Healthcare
Webinar Date
February 14, 2019
| | Original Course Date: February 14, 2019
| MORE INFO |
|
From the Society for Immunotherapy of Cancer's (SITC) Advances in Cancer Immunotherapy™ (ACI) educational series, this course provides an overview on cancer immunotherapy for the treatment of Head and Neck Cancers and immune related adverse event management. The on-demand webinar, hosted by Drs. Brekken (UT Southwestern Medical Center) and Khan (UT Southwestern Medical Center), gives an update on immunotherapy for the treatment of head and neck cancers and irAE management. Stay up to date with the most recent clinical recommendations and research by exploring the curated Additional Resources tab.
Target Audience
The target audience includes clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians, allied health professionals, other patient care providers, students and patient advocates. The course is designed to help all members of the cancer health care team stay connected with updates in the field of cancer immunotherapy.
SITC Online Education Disclaimer
A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
Course Available Beginning: February 19, 2019
| | Original Course Date: January 31, 2019
| MORE INFO |
|
From the Society for Immunotherapy of Cancer's (SITC) Advances in Cancer Immunotherapy™ (ACI) educational series, this course provides an overview on cancer immunotherapy for the treatment of melanoma and immune related adverse event management. The on-demand webinars, hosted by Dr. Lawson (Winship Cancer Institute of Emory University), and Dr. Lutzky (Mount Sinai Medincal Center) and, nurse, Jeanelle King (Mount Sinai Medical Center), gives an update on immunotherapy for the treatment of melanoma and immune related adverse event management. Stay up to date with the most recent clinical recommendations and research by exploring the curated Additional Resources tab.
Target Audience
The target audience includes clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians, allied health professionals, other patient care providers, students and patient advocates. The course is designed to help all members of the cancer health care team stay connected with updates in the field of cancer immunotherapy.
SITC Online Education Disclaimer
A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
Course Available Beginning: February 19, 2019
| | Original Course Date: January 31, 2019
| MORE INFO |
|
From the Society for Immunotherapy of Cancer's (SITC) Advances in Cancer Immunotherapy™ (ACI) educational series, this course provides an overview on cancer immunotherapy for the treatment of melanoma and immune related adverse event management. The on-demand webinar, hosted by Drs. Hwu (University of MD Anderson Cancer Center), Cascone (University of Texas MD Anderson Cancer Center) and, registered nurse, Michelle Rohlfs (University of Texas MD Anderson Cancer Center), gives an update on immunotherapy for the treatment of lung cancers and immune related adverse event management. Stay up to date with the most recent clinical recommendations and research by exploring the curated Additional Resources tab.
Target Audience
The target audience includes clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians, allied health professionals, other patient care providers, students and patient advocates. The course is designed to help all members of the cancer health care team stay connected with updates in the field of cancer immunotherapy.
SITC Online Education Disclaimer
A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
Course Available Beginning: February 19, 2019
| | Original Course Date: January 31, 2019
| MORE INFO |
|
From the Society for Immunotherapy of Cancer's (SITC) Advances in Cancer Immunotherapy™ (ACI) educational series, this course provides an overview on cancer immunotherapy for the treatment of Hematologic Malignancies and immune-related adverse event mangement. The on-demand webinars, hosted by Drs. Capitini (University of Wisconsin Carbone Cancer Center) and Li (MUSC Hollings Cancer Center), gives an update on immunotherapy for the treatment of hematologic malignanices and immune-related adverse event management. Stay up to date with the most recent clinical recommendations and research by exploring the curated Additional Resources tab.
Target Audience
The target audience includes clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians, allied health professionals, other patient care providers, students and patient advocates. The course is designed to help all members of the cancer health care team stay connected with updates in the field of cancer immunotherapy.
SITC Online Education Disclaimer
A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
Course Available Beginning: February 19, 2019
| | Original Course Date: January 31, 2019
| MORE INFO |
|
From the Society for Immunotherapy of Cancer's (SITC) Advances in Cancer Immunotherapy™ (ACI) educational series, this course provides an overview on practial barriers to implementing immunotherapy into clinical practice and immune-related adverse event management in the emergency setting. The on-demand webinars, hosted by Jacqueline Caban (Yale New Haven Health System), Jeff Liticker (UT Southwestern Medical Center) and Sanjiv S. Agarwala (St. Luke's Cancer Center and Temple University), gives an update on practial barriers to implementing immunotherapy into clinical practice and immune related adverse event management in the emergency setting. Stay up to date with the most recent clinical recommendations and research by exploring the curated Additional Resources tab.
Target Audience
The target audience includes clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians, allied health professionals, other patient care providers, students and patient advocates. The course is designed to help all members of the cancer health care team stay connected with updates in the field of cancer immunotherapy.
SITC Online Education Disclaimer
A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
Course Available Beginning: February 19, 2019
| | Original Course Date: January 31, 2019
| MORE INFO |
| View Recorded Webinar
Program Summary
This one-hour webinar, moderated by Sruthi Ravindranathan, PhD (Emory University), and presented by Vionnie W.C. Yu, PhD (Novartis Institutes for Biomedical Research), provided strategies and tactics for a successful career in industry. The webinar will featured an opportunity for Q&A - an open forum for attendees to connect with these experts in the field!
These webinars are an extension of the Meet-the-Expert Lunch, a Pre-Conference Program of the SITC Annual Meeting, providing a unique educational forum for early career scientists. This popular program connects early career scientists with field experts who provide guidance on a variety of career-related topics.
Webinar Faculty
Sruthi Ravindranathan, PhD - Emory Univeristy
Vionnie W. C. Yu, PhD - Novartis Institutes for Biomedical Research
Webinar Date
January 17, 2019
| | Original Course Date: January 17, 2019
| MORE INFO |
| View Recorded Webinar
Program Summary
Watch this free, one-hour webinar, presented by Sruthi Ravindranathan, PhD (Emory University) to learn about strategies and tactics for how to kick start your career in the US. The webinar featured an opportunity for Q&A - an open forum for you to connect with these experts in the field!
These webinars are an extension of the Meet-the-Expert Lunch, a Pre-Conference Program of the SITC Annual Meeting, providing a unique educational forum for early career scientists. This popular program connects early career scientists with field experts who provide guidance on a variety of career-related topics.
Webinar Faculty
Sruthi Ravindranathan, PhD - Emory University
Webinar Date
January 17, 2019
| | Original Course Date: January 17, 2019
| MORE INFO |
| View Recorded Webinar
Program Summary
This free, one-hour webinar, moderated by Tullia Bruno, PhD (University of Pittsburgh), and presented by Greg Delgoffe, PhD (University of Pittsburgh) and Charles Drake, MD, PhD (Columbia University Medical Center), to learn about strategies and tactics for how to survive in academia. The webinar featured an opportunity for Q&A - an open forum for you to connect with these experts in the field!
These webinars are an extension of the Meet-the-Expert Lunch, a Pre-Conference Program of the SITC Annual Meeting, providing a unique educational forum for early career scientists. This popular program connects early career scientists with field experts who provide guidance on a variety of career-related topics.
Webinar Faculty
Tullia Bruno, PhD - University of Pittsburgh
Greg Delgoffe, PhD - University of Pittsburgh
Charles Drake, MD, PhD - Columbia University Medical Center
Webinar Date
January 17, 2019
| | Original Course Date: January 17, 2019
| MORE INFO |
| View Recorded Webinar
Program Summary
With cutting-edge data regularly emerging from conferences and new FDA approvals, keeping updated with the latest cancer immunotherapy research is an arduous task for a practicing clinician. To complement and expand upon the live Advances in Cancer Immunotherapy™ (ACI) programs, SITC is proud to offer a series of quarterly webinars to highlight the latest advancements and trends in the field as they relate to clinical practice.
The focus of this webinar is on clinical updates from the Society for Immunotherapy of Cancer 33rd Annual Meeting and Pre-Conference Programs (SITC 2018).
Webinar Faculty
Christian M. Capitini, MD - University of Wisconsin Carbone Cancer Center
Zachary S. Morris, MD, PhD - University of Wisconsin School of Medicine and Public Health
Webinar Date
December 10, 2018
| | Original Course Date: December 10, 2018
| MORE INFO |
| View Recorded Webinar
Program Summary
With cutting-edge data regularly emerging from conferences and new FDA approvals, keeping updated with the latest cancer immunotherapy research is an arduous task for a practicing clinician. To complement and expand upon the live Advances in Cancer Immunotherapy™ (ACI) programs, SITC is proud to offer a series of quarterly webinars to highlight the latest advancements and trends in the field as they relate to clinical practice.
The focus of this webinar is on clinical trials presented at ESMO Congress 2018.
Webinar Faculty
Theodore F. Logan, MD - Indiana University Simon Cancer Center
David F. McDermott, MD - Beth Israel Deaconess Medical Center
Webinar Date
November 15, 2018
| | Original Course Date: November 15, 2018
| MORE INFO |
| The Global Promise of Cancer Immunotherapy Recorded Webinar provides education for patients, caregivers, and patient advocates on how the immune system can be harnessed to fight cancer. The Jan. 30, 2018 webinar, provided by the Society for Immunotherapy of Cancer (SITC), was provided in collaboration with the European Cancer Patient Coalition (ECPC).
Presenters of the webinar were Howard L. Kaufman, MD, FACS, an expert in the cancer immunotherapy field and past SITC president, and Jacqueline Smith, MS, MA, a cancer survivors who has been successfully treated with cancer immunotherapy.
The recorded webinar includes a question and answer session in which webinar attendees asked questions and received guidance and feedback from the webinar presenters. The question and answer session includes discussion on clinical trials, side effects, and insurance coverage.
Webinar Faculty
Howard L. Kaufman MD, FACS
Jacqueline Smith MS, MA
Webinar Date
January 30, 2018
View Recorded Webinar
Click here to access the recorded webinar.
The Society for Immunotherapy of Cancer is pleased to offer the recorded webinar with subtitles in Spanish, Portuguese, simplified Chinese, and Hindi along with translated versions of the accompanying slides. Please click on one of the links below to view translated webinar recording and translated slide deck.
Promesa Global de la Inmunoterapia Contra el Cáncer - Spanish
A Promessa Global da Imunoterapia para o tratamento do Câncer – Portuguese
Simplified Chinese
Hindi
This webinar was produced with generous support from EMD Serono. EMD Serono, is the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada.
| | Original Course Date: January 30, 2018
| MORE INFO |
|
|